These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12023676)

  • 1. Subgroup analysis of the NORDIL trial.
    Thijs L; Staessen JA; Wang J; Fagard R
    J Hypertens; 2002 Jun; 20(6):1085-7. PubMed ID: 12023676
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
    Kjeldsen SE; Hedner T; Syvertsen JO; Lund-Johansen P; Hansson L; Lanke J; Lindholm LH; De Faire U; Dahlöf B; Karlberg BE;
    J Hypertens; 2002 Jun; 20(6):1231-7. PubMed ID: 12023696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
    Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE
    Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Avanzini F; Tognoni G
    Lancet; 2000 Dec; 356(9245):1927-8; author reply 1928-9. PubMed ID: 11130404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers in systemic hypertension.
    Frishman WH; Charlap S; Michelson EL
    Am J Cardiol; 1986 Jul; 58(1):157-60. PubMed ID: 3524178
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group.
    Kanamasa K; Kimura A; Miyataka M; Takenaka T; Ishikawa K
    Cancer; 1999 Mar; 85(6):1369-74. PubMed ID: 10189144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diltiazem after thrombolysis.
    Drummond GA
    Lancet; 2000 Nov; 356(9241):1604-5. PubMed ID: 11075793
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcium antagonists in arterial hypertension].
    Muiesan G
    G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993
    [No Abstract]   [Full Text] [Related]  

  • 11. Diltiazem comes in from the cold.
    Purcell H; Fox K
    Eur Heart J; 2001 Feb; 22(3):185-7. PubMed ID: 11161925
    [No Abstract]   [Full Text] [Related]  

  • 12. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
    Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
    Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is diltiazem as effective as diuretics and beta-blockers in preventing complications from hypertension?
    Adelman A
    J Fam Pract; 2000 Nov; 49(11):1049. PubMed ID: 11093573
    [No Abstract]   [Full Text] [Related]  

  • 14. Diltiazem-induced photodistributed hyperpigmentation.
    Boyer M; Katta R; Markus R
    Dermatol Online J; 2003 Dec; 9(5):10. PubMed ID: 14996383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dilzem - a new calcium antagonist is introduced].
    Bohl E
    ZFA (Stuttgart); 1982 Feb; 58(5):292-6. PubMed ID: 7080650
    [No Abstract]   [Full Text] [Related]  

  • 16. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
    Messerli FH; Hansen JF; Gibson RS; Schechtman KB; Boden WE
    J Hypertens; 2001 May; 19(5):977-82. PubMed ID: 11393682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nordic Diltiazem Study (NORDIL). A prospective intervention trial of calcium antagonist therapy in hypertension.
    Blood Press; 1993 Dec; 2(4):312-21. PubMed ID: 8173702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium entry blockers for systemic hypertension.
    Moser M
    Am J Cardiol; 1987 Jan; 59(2):115A-121A. PubMed ID: 3028116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.